TY - JOUR
T1 - Kinetics of marked development of lung metastasis of rat prostatic carcinomas transplanted in syngeneic rats
AU - Zhao, Laiyuan
AU - Futakuchi, Mitsuru
AU - Suzuki, Shugo
AU - Ohhara, Yoshiaki
AU - Hashimoto, Takashi
AU - Suzuki, Tatsuya
AU - Manabe, Tadao
AU - Shirai, Tomoyuki
N1 - Funding Information:
This work was supported in part by a grants-aid for Cancer Research from the Ministry of Education, Sports, Science and Culture, and the Ministry of Health and Welfare of Japan, a grant-in-aid from the Ministry of Health and Welfare for the Second Term Comprehensive 10-Year Strategy for Cancer Control, Japan, and a grant from the Society for Promotion of Pathology of Nagoya, Japan.
PY - 2005/1
Y1 - 2005/1
N2 - In order to investigate how and when metastases develop under experimental conditions, kinetics of the size and the number of lung metastasis lesions in F344 rats were examined after syngeneic transplantation of rat prostate carcinomas induced by 3,2′-dimethyl-4-aminobiphenyl (DMAB). Cell proliferation of the subcutaneous tumor and lung metastatic lesions was evaluated along with the expression of VEGF-A splicing variants and endostatin, serum VEGF levels and vascular density in the tumor. Several pieces of tumor tissue were introduced subcutaneously into two different sites on the dorsal side of F344 rats through a 14G needle. Average body weight of recipient rats markedly decreased despite only a gradual increase in tumor volume. The absolute total number of metastatic lesions in rats (n=5) were 2, 10, 19 and 194 at weeks 7.5, 9, 11 and 13, respectively, and a notable increase was observed at week 13. Similarly, the mitotic index of lung metastatic lesions increased remarkably at week 9 while the mitotic index and apoptotic index of transplanted tumors did not change throughout the experimental period. Expression of VEGF-A121, A164, A188 and endostatin, serum VEGF levels and vascular density did not correlate with the spread of lung lesions. In conclusion, both the number and the size of metastatic lesions increased at the same time after a notable increase in cell proliferation. Factors other than VEGF or endostatin may be involved in the mechanism of explosive lung metastasis spread.
AB - In order to investigate how and when metastases develop under experimental conditions, kinetics of the size and the number of lung metastasis lesions in F344 rats were examined after syngeneic transplantation of rat prostate carcinomas induced by 3,2′-dimethyl-4-aminobiphenyl (DMAB). Cell proliferation of the subcutaneous tumor and lung metastatic lesions was evaluated along with the expression of VEGF-A splicing variants and endostatin, serum VEGF levels and vascular density in the tumor. Several pieces of tumor tissue were introduced subcutaneously into two different sites on the dorsal side of F344 rats through a 14G needle. Average body weight of recipient rats markedly decreased despite only a gradual increase in tumor volume. The absolute total number of metastatic lesions in rats (n=5) were 2, 10, 19 and 194 at weeks 7.5, 9, 11 and 13, respectively, and a notable increase was observed at week 13. Similarly, the mitotic index of lung metastatic lesions increased remarkably at week 9 while the mitotic index and apoptotic index of transplanted tumors did not change throughout the experimental period. Expression of VEGF-A121, A164, A188 and endostatin, serum VEGF levels and vascular density did not correlate with the spread of lung lesions. In conclusion, both the number and the size of metastatic lesions increased at the same time after a notable increase in cell proliferation. Factors other than VEGF or endostatin may be involved in the mechanism of explosive lung metastasis spread.
UR - http://www.scopus.com/inward/record.url?scp=25444492826&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=25444492826&partnerID=8YFLogxK
U2 - 10.1007/s10585-005-0054-8
DO - 10.1007/s10585-005-0054-8
M3 - Article
C2 - 16170667
AN - SCOPUS:25444492826
SN - 0262-0898
VL - 22
SP - 309
EP - 318
JO - Clinical and Experimental Metastasis
JF - Clinical and Experimental Metastasis
IS - 4
ER -